Business Segments · D&A
PDx — D&A
GE HealthCare Technologies PDx — D&A increased by 11.1% to $20.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 66.7%, from $12.00M to $20.00M. Over 3 years (FY 2022 to FY 2025), PDx — D&A shows an upward trend with a 13.6% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026
Rolls up toD&A
How to read this metric
An increase often reflects significant recent capital investment or acquisition activity, while a stable level indicates consistent asset utilization.
Detailed definition
The non-cash expense allocated to the Pharmaceutical Diagnostics segment for the wear and tear of tangible assets and th...
Peer comparison
Standard D&A metric found in segment notes for capital-intensive manufacturing and technology companies.
Metric ID:
gehc_segment_pdx_depreciation_and_amortizationHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $11.25M | $11.25M | $11.25M | $11.25M | $11.25M | $11.25M | $11.25M | $11.25M | $16.00M | $15.00M | $12.00M | $12.00M | $12.00M | $17.00M | $19.00M | $18.00M | $20.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +42.2% | -6.3% | -20.0% | +0.0% | +0.0% | +41.7% | +11.8% | -5.3% | +11.1% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +42.2% | +33.3% | +6.7% | +6.7% | -25.0% | +13.3% | +58.3% | +50.0% | +66.7% |
Range$11.25M – $20.00M
CAGR+15.5%
Avg YoY Growth+19.4%
Median YoY Growth+6.7%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is GE HealthCare Technologies's pdx — d&a?
- GE HealthCare Technologies (GEHC) reported pdx — d&a of $20.00M in Q1 2026.
- How has GE HealthCare Technologies's pdx — d&a changed year-over-year?
- GE HealthCare Technologies's pdx — d&a increased by 66.7% year-over-year, from $12.00M to $20.00M.
- What is the long-term trend for GE HealthCare Technologies's pdx — d&a?
- Over 3 years (2022 to 2025), GE HealthCare Technologies's pdx — d&a has grown at a 13.6% compound annual growth rate (CAGR), from $45.00M to $66.00M.
- What does pdx — d&a mean?
- The non-cash cost representing the allocation of the cost of tangible and intangible assets over their useful lives for the segment.